- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
TOP MEDICAL NEWS 10/AUGUST/2022 - Video
Overview
1.Robotic-assisted lobectomy for early-stage lung cancer provides better patient-reported quality of life compared to video-assisted lobectomy.
Dr. Patel, from four academic sites in the United States, Canada, and France enrolled 406 patients with early-stage lung cancer who were candidates for minimally invasive lobectomy. Patients were randomized to receive either RTS-Lobectomy which is intervention or VATS-Lobectomy thats is control.
Ref:
Dr. Yogita S. Patel et. al, INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER, MEETING IASLC World Conference on Lung Cancer 2022, 9-AUG-2022
2. Risk factors for patients with lung cancer who have never smoked
To assess the connection between pollution and lung cancer diagnosis, Renelle Myers and their team compared the cumulative three-year versus 20-year exposure in females with newly diagnosed lung cancer who have never smoked.
The researchers collected detailed information on the patient's age, sex, race, country of birth, age of arrival in Canada (for foreign-born Canadians), occupation, family history of lung cancer, and secondhand smoke exposure. A detailed residential history from birth to cancer diagnosis for residences within Canada, and prior residences outside of Canada (for foreign-born immigrants) were recorded.
Ref:
Renelle Myers et. al, MEETING IASLC World Conference on Lung Cancer 2022,
Sexual dysfunction is highly prevalent in women with lung cancer with most survey participants reporting little to no interest in sexual activity, according to research led by Narjust Florez.
Reporting results of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) study, researchers show marked differences in sexual desire/interest and vaginal pain/discomfort when comparing before and after a lung cancer diagnosis.
The SHAWL study is an observational, cross-sectional, international survey administered via the GO2 Foundation for Lung Cancer and the Lung Cancer Registry. The study utilized the Patient-Reported Outcomes Measurement Information System (PROMIS®) Sexual Function and Satisfaction Measures (a validated questionnaire) to evaluate sexual health.
Ref:
Narjust Florez et. al, Sexual dysfunction high among women with lung cancer, DANA-FARBER CANCER INSTITUTE,9-AUG-2022
4. Lung cancer risk prediction nomogram for female non-smokers
About 53% of lung cancers in females are not attributable to smoking worldwide and a new model presented at the IASLC World Conference on Lung Cancer may allow clinicians the ability to assess and stratify lung cancer risk in female non-smokers in China.
Lanwei Guo, & team examined data from 151,834 patients in China, from October 2013 to October 2019 from the Cancer Screening Program in Urban China.
The aim was to develop and validate a simple and non-invasive model which could assess and stratify lung cancer risk in female non-smokers in China. Ref:
Lanwei Guo et. al, MEETING, IASLC World Conference on Lung Cancer 2022, 9-Aug-2022
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed